GlassScriptPhysician profile
Barry M Pisick
NPI 1427138130
$1,814.70
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.11 · 2021: $235 · 2022: $445 · 2023: $1,019 · 2024: $18.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,038.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,037.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $819.77 | 2021-2023 | Fasenra, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $224.74 | 2019-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Mylan Specialty L.P. | $221.25 | 2022-2023 | Yupelri |
| Mallinckrodt Hospital Products INC. | $116.23 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $93.47 | 2022-2023 | Dupixent |
| Electromed, INC. | $62.06 | 2022-2023 | Smartvest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.77 | 2019-2023 | Spiriva Respimat, Ofev |
| Grifols USA, LLC | $59.93 | 2023 | Prolastin-C Liquid, Xembify |
| United Therapeutics Corporation | $41.23 | 2023 | Tyvaso |
| Harmony Biosciences LLC | $37.32 | 2022-2023 | Wakix |
| Novartis Pharmaceuticals Corporation | $31.97 | 2023 | |
| Baxter Healthcare | $25.48 | 2023 | Hillrom - Volara System |
| Takeda Pharmaceuticals U.S.A., INC. | $20.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Pisick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.